• KOL
    • Platelet Activation
    • Elsa Pennese
    • Elsa Pennese: Influence Statistics

      Elsa Pennese

      Elsa Pennese

      U.O.S.D. Centro Diagnosi e Terapia dei Linfomi, Dipartimento Oncologico-Ematologico, Presidio Ospedaliero "Spirito Santo", Pescara | Lymphoma Unit, Department of Hematology, ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Elsa Pennese:Expert Impact

      Concepts for whichElsa Pennesehas direct influence:Platelet activation,Vivo formation,Geriatric assessment,Targeted drugs,Diabetes mellitus,Patients cll,Diffuse large,Patients dlbcl.

      Elsa Pennese:KOL impact

      Concepts related to the work of other authors for whichfor which Elsa Pennese has influence:Oxidative stress,Lipid peroxidation,Diabetes mellitus,Platelet activation,Type 2,Diabetic patients,Cardiovascular disease.

      KOL Resume for Elsa Pennese

      Year
      2022

      U.O.S.D. Centro Diagnosi e Terapia dei Linfomi, Dipartimento Oncologico-Ematologico, Presidio Ospedaliero "Spirito Santo", Pescara

      2021

      Lymphoma Unit, Department of Hematology, Ospedale Spirito Santo, Pescara, Italy.

      2019

      Lymphoma Unit, Department of Hematology, Ospedale Spirito Santo, Pescara, Italy

      1999

      From the Departments of Medicine and Aging (G.D., A.C., A.M., S.S., E.P., E.V., F. Costantini, F. Capani, C.P.) and Biomedical Sciences (T.B.), University of Chieti “G. D’Annunzio” School of Medicine; the Division of Internal Medicine, Civil Hospital of Popoli (A.F.); and the Department of Pharmacology (G.C.), Catholic University School of Medicine; Rome, Italy.

      Sample of concepts for which Elsa Pennese is among the top experts in the world.
      Concept World rank
      urinary 8isopgf2alpha excretion #31
      thromboxane txm #34
      txm excretion #66
      urinary 8isopgf2alpha #69
      pgf2alpha excretion #82
      urinary txm #83
      arachidonic acid peroxidation #88

      Prominent publications by Elsa Pennese

      KOL-Index: 12941

      BACKGROUND: Diabetes mellitus (DM) is associated with enhanced lipid peroxidation and persistent platelet activation. We tested the hypothesis that the in vivo formation of the F2-isoprostane 8-iso-prostaglandin (PG)F2alpha, a bioactive product of arachidonic acid peroxidation, is enhanced in DM and contributes to platelet activation.

      METHODS AND RESULTS: Urine samples were obtained from 85 diabetic patients and 85 age- and sex-matched healthy subjects for measurement of immunoreactive ...

      Known for Platelet Activation | Diabetes Mellitus | Vivo Formation | 8 Iso | Vitamin Supplementation
      KOL-Index: 4957

      PURPOSE: To prospectively validate the use of a simplified geriatric assessment (sGA) at diagnosis and to integrate it into a prognostic score for older patients with diffuse large B-cell lymphoma (DLBCL).

      METHODS: We conducted the prospective Elderly Project study on patients with DLBCL older than 64 years who underwent our Fondazione Italiana Linfomi original geriatric assessment (oGA) (age, Cumulative Illness Rating Scale for Geriatrics, activities of daily living, and instrumental ...

      Known for Geriatric Assessment | Diffuse Large | Patients Dlbcl | Cell Lymphoma | Multivariate Analysis
      KOL-Index: 4745

      Autoimmune cytopenias (AICs) affect 5% to 9% of patients with chronic lymphocytic leukemia (CLL). Targeted drugs-ibrutinib, idelalisib, and venetoclax-have a prominent role in the treatment of CLL, but their impact on CLL-associated AICs is largely unknown. In this study, we evaluated the characteristics and outcome of preexisting AICs and described the incidence, quality, and management of treatment-emergent AICs during therapy with targeted drugs in patients with CLL. We collected data ...

      Known for Targeted Drugs | Patients Cll | Venetoclax Therapy | Treated Ibrutinib | Anti Cd20

      Key People For Platelet Activation

      Top KOLs in the world
      #1
      Alan D Michelson
      platelet activation flow cytometry aspirin resistance
      #2
      Sanford J Shattil
      alpha iib platelet activation tyrosine phosphorylation
      #3
      Meinrad Paul Gawaz
      platelet activation endothelial cells thrombus formation
      #4
      Zaverio M Ruggeri
      willebrand factor platelet adhesion thrombus formation
      #5
      Bernhard Nieswandt
      thrombus formation platelet activation ischemic stroke
      #6
      Denisa D Wagner
      willebrand factor endothelial cells deep vein thrombosis

      U.O.S.D. Centro Diagnosi e Terapia dei Linfomi, Dipartimento Oncologico-Ematologico, Presidio Ospedaliero "Spirito Santo", Pescara | Lymphoma Unit, Department of Hematology, Ospedale Spirito Santo, Pescara, Italy. | Unità Operativa Semplice Dipartime

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.